This podcast episode explores Bayer's recent struggles and the company's efforts to shake up its organizational structure. Bayer has faced setbacks in drug trials and lawsuits, leading to a decline in its stock price. To address these challenges, the company has hired a new CEO, Bill Anderson, who is implementing a new structure called "dynamic shared ownership." This involves empowering employees to make decisions without layers of approval and organizing them into small teams that will operate independently. Anderson believes that this approach will streamline operations, foster innovation, and increase employee engagement.
